ADPT
Adaptive Biotechnologies Corp

4,281
Mkt Cap
$2.57B
Volume
832,034.00
52W High
$17.89
52W Low
$4.27
PE Ratio
-20.76
ADPT Fundamentals
Price
$16.90
Prev Close
$17.12
Open
$17.01
50D MA
$14.24
Beta
1.97
Avg. Volume
2M
EPS (Annual)
-$1.08
P/B
14.32
Rev/Employee
$289,106.62
Loading...
Loading...
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
619

Frequently Asked Questions

What is Market Cap of Adaptive Biotechnologies Corp?
What is the 52-week high for Adaptive Biotechnologies Corp?
What is the 52-week low for Adaptive Biotechnologies Corp?
What is Adaptive Biotechnologies Corp stock price today?
What was Adaptive Biotechnologies Corp stock price yesterday?
What is the PE ratio of Adaptive Biotechnologies Corp?
What is the Price-to-Book ratio of Adaptive Biotechnologies Corp?
What is the 50-day moving average of Adaptive Biotechnologies Corp?
How many employess does Adaptive Biotechnologies Corp has?

Latest ADPT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.